Thus, it remains to be established if this model can be assessed for the development of insulin resistance by studying GLUT4 transport at the liver or dyslipidemia by studying markers of lipid export (e.g., FABP2-4), both at liver and adipose tissues. This evidence concerns the gene SLC2A4 and Insulin resistance.